Request for Proposals to fund quality-improvement projects that strengthen antimicrobial stewardship (AMS) across Sub-Saharan Africa. Projects should be context-sensitive, implementation-focused (not clinical efficacy research), and align with strategic objectives such as strengthening AMS practices, improving antibiotic access and rational use, enhancing AMR surveillance and diagnostics, and building sustainable systems for impact and scale.
Eligibility Criteria:
-
Geography: Lead applicant/entity based in Sub-Saharan Africa; activities at regional, sub-regional, or national level in Africa.
-
Who Can Apply: Academic/research institutions, intergovernmental organizations, regional economic communities, scientific associations/societies, NGOs, and other entities with demonstrated AMR commitment in SSA; qualified individuals may also apply.
-
Partnerships: Collaboration strongly encouraged (e.g., with universities, hospitals/health systems, public health institutions, regulators, or professional societies). Partners must have defined roles; the lead applicant plays a central role. Grass-roots/local organizations and projects targeting vulnerable populations prioritized.
-
Project Fit: QI initiatives only (not clinical efficacy research); include clear pathways for implementation, monitoring & evaluation, and sustainability.
Funding Details:
-
Budget Per Award: Up to USD 100,000.
-
Total Program Budget/Number Of Awards: USD 400,000 total; expected 4–6 awards.
-
Project Duration: Up to 24 months (anticipated Jan 2026–Dec 2027 performance period).
-
Use Of Funds: Per QI grant rules; subject to Pfizer grant agreement terms and overhead policy.
Deadline:
-
Full Proposal Due: October 4, 2025 (11:59 p.m. Eastern Time, New York).
-
Panel Review: October 2025.
-
Notifications: October–November 2025.
-
Grant Disbursement (post-agreement): December 2025.
-
Period Of Performance: January 2026 – December 2027.
Where To Go For Further Information: